IRIS Accounts Production v24.3.2.46 05571932 Board of Directors 31.3.23 30.3.24 30.3.24 No description of principal activity 0 0 false true false false true true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055719322023-03-30055719322024-03-30055719322023-03-312024-03-30055719322022-03-30055719322022-03-312023-03-30055719322023-03-3005571932ns15:EnglandWales2023-03-312024-03-3005571932ns14:PoundSterling2023-03-312024-03-3005571932ns10:Director12023-03-312024-03-3005571932ns10:PrivateLimitedCompanyLtd2023-03-312024-03-3005571932ns10:SmallEntities2023-03-312024-03-3005571932ns10:AuditExempt-NoAccountantsReport2023-03-312024-03-3005571932ns10:SmallCompaniesRegimeForDirectorsReport2023-03-312024-03-3005571932ns10:SmallCompaniesRegimeForAccounts2023-03-312024-03-3005571932ns10:FullAccounts2023-03-312024-03-3005571932ns10:Director22023-03-312024-03-3005571932ns10:Director32023-03-312024-03-3005571932ns10:Director42023-03-312024-03-3005571932ns10:RegisteredOffice2023-03-312024-03-3005571932ns5:CurrentFinancialInstruments2024-03-3005571932ns5:CurrentFinancialInstruments2023-03-3005571932ns5:ShareCapital2024-03-3005571932ns5:ShareCapital2023-03-3005571932ns5:FurtherSpecificReserve1ComponentTotalEquity2024-03-3005571932ns5:FurtherSpecificReserve1ComponentTotalEquity2023-03-3005571932ns5:RetainedEarningsAccumulatedLosses2024-03-3005571932ns5:RetainedEarningsAccumulatedLosses2023-03-3005571932ns5:PlantMachinery2023-03-3005571932ns5:PlantMachinery2024-03-3005571932ns5:PlantMachinery2023-03-3005571932ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3005571932ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-30
REGISTERED NUMBER: 05571932 (England and Wales)
















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 MARCH 2024

FOR

SOVEREIGN SURGICAL GROUP LTD

SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2024










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4

SOVEREIGN SURGICAL GROUP LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 MARCH 2024







DIRECTORS: Mr G Hills
Mrs J S Hills
Mr G D Griffiths
Mrs L A Griffiths





REGISTERED OFFICE: Lawrence House
5 St Andrews Hill
Norwich
Norfolk
NR2 1AD





REGISTERED NUMBER: 05571932 (England and Wales)

SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

STATEMENT OF FINANCIAL POSITION
30 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 127 127

CURRENT ASSETS
Debtors 5 30 30

CREDITORS
Amounts falling due within one year 6 89,050 89,050
NET CURRENT LIABILITIES (89,020 ) (89,020 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(88,893

)

(88,893

)

CAPITAL AND RESERVES
Called up share capital 300 300
Capital reserve 6,840 6,840
Retained earnings (96,033 ) (96,033 )
SHAREHOLDERS' FUNDS (88,893 ) (88,893 )

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 30 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

STATEMENT OF FINANCIAL POSITION - continued
30 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 January 2025 and were signed on its behalf by:





Mr G Hills - Director


SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2024


1. STATUTORY INFORMATION

Sovereign Surgical Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company was dormant throughout the current year and previous year.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 25% on reducing balance
Computer equipments - 25% on reducing balance

SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 MARCH 2024


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognized in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognized amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies that are classified as debt, are initially recognized at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payment discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

GOING CONCERN
The company's balance sheet shows a net deficit of £88,893 (£88,893- 2023) in shareholders fund position. However, the director's have received confirmation from the shareholders of their continued financial support for the foreseeable future and for at least twelve months from the date of signature of these accounts.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

SOVEREIGN SURGICAL GROUP LTD (REGISTERED NUMBER: 05571932)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 MARCH 2024


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
Cost
At 31 March 2023
and 30 March 2024 3,755
Depreciation
At 31 March 2023
and 30 March 2024 3,628
Net book value
At 30 March 2024 127
At 30 March 2023 127

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 30 30

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other creditors 89,050 89,050